CMS Publishes Grab Bag of Proposed Changes to the Medicaid Drug Rebate Program
FDA Law
JUNE 2, 2023
Kirschenbaum — Last Friday, May 26, CMS published in the Federal Register an assortment of proposals to change the regulations governing the Medicaid Drug Rebate Program. This limitation is virtually unenforceable because prescriptions and Medicaid claims for drugs do not identify the patient’s diagnosis or condition.
59 
Let's personalize your content